Duchenne UK
Overview
Duchenne UK is a UK-based medical research charity that funds and accelerates research and the development of treatments to end Duchenne muscular dystrophy (DMD).
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MetrioPharm AG | Oct 2022 | Grant | Lead |
| Evox Therapeutics | Nov 2018 | Grant | Co-investor |
| Myogenica, Inc. | Apr 2024 | Grant | Co-investor |
| MyoGene Bio | Nov 2025 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Duchenne UK based?
Duchenne UK is headquartered in London, United Kingdom.
When was Duchenne UK founded?
Duchenne UK was founded in 2012.
How many portfolio companies does Duchenne UK have?
Duchenne UK has 4 portfolio companies in Caplight's dataset.
What are some companies in Duchenne UK's portfolio?
Portfolio companies visible on Caplight include MetrioPharm AG, Evox Therapeutics, Myogenica, Inc., MyoGene Bio.
What was Duchenne UK's most recent investment shown here?
Duchenne UK's most recent investment in this portfolio sample was in MyoGene Bio in 2025.
What sectors does Duchenne UK focus on?
Duchenne UK focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Duchenne UK focus on?
Stage focus information for Duchenne UK is not publicly available.